Zelira Therapeutics Limited (OTCMKTS:ZLDAF – Get Free Report) was down 6% during trading on Thursday . The company traded as low as $0.33 and last traded at $0.33. Approximately 200 shares were traded during trading, a decline of 20% from the average daily volume of 250 shares. The stock had previously closed at $0.35.
Zelira Therapeutics Trading Down 6.0 %
The stock’s 50 day moving average price is $0.39 and its 200 day moving average price is $0.45.
About Zelira Therapeutics
Zelira Therapeutics Limited, a bio-pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based medicines for the treatment of various medical conditions in Australia and the United States. The company offers formulations under the HOPE brand in Australia, Washington, Pennsylvania, and Louisiana, as well as develops Zenivol, a cannabinoid-based medicine for treatment of chronic insomnia.
Featured Stories
- Five stocks we like better than Zelira Therapeutics
- Options Trading – Understanding Strike Price
- Market Momentum: 3 Stocks Poised for Significant Breakouts
- Basic Materials Stocks Investing
- Kinder Morgan’s Uptrend is Only Half Over: New Highs Are Coming
- Retail Stocks Investing, Explained
- Momentum Builders: 3 Stocks Positioned to Shine This Quarter
Receive News & Ratings for Zelira Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zelira Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
